一分钟看懂
这是一项关于胰腺癌的II 期 / III 期研究，登记的药物或干预包括Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine；Nab-paclitaxel Plus Gemcitabine；Surufatinib with Nab-paclitaxel, and，当前状态为招募中。登记地点显示中国合肥、北京、重庆、福州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine；Nab-paclitaxel Plus Gemcitabine；Surufatinib with Nab-paclitaxel, and Gemcitabine · II 期 / III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Anhui Provincial Hospital · 合肥
- Beijing Cancer Hospital · 北京
- Peking Union Medical College Hospital · 北京
- Peking University Third Hospital · 北京
- Chongqing General Hospital · 重庆
- Chongqing University Cancer Hospital · 重庆
- Fujian Cancer Hospital · 福州
- The First Affiliated Hospital of Xiamen University · 厦门
- Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center · 深圳
- The First Affiliated Hospital of Guangxi Medical University · 南宁
- Guangdong Provincial People's Hospital · 广东省
- Hainan General Hospital · 海口
- First Hospital of Qinhuangdao · 秦皇岛
- Harbin Medical University Cancer Hospital · 哈尔滨
- Anyang Cancer Hospital · 安阳
- The First Affiliated Hospital of Henan Medical University · 新乡
- Henan Cancer Hospital · 郑州
- The First Affiliated Hospital of Zhengzhou University · 郑州
- Hubei Cancer Hospital · 武汉
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology · 武汉
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · 武汉
- Hunan Cancer Hospital · 长沙
- XiangYa Hospital CentralSouth University · 长沙
- Jiangsu Cancer Hospital · 南京
- Nanjing Drum Tower Hospital · 南京
- Nanjing Tianyinshan Hospital · 南京
- Nantong Cancer Hospital · 南通
- The First Affiliated Hospital of Soochow University · 苏州
- Jiangyin People's Hospital · 无锡
- Jiangxi Cancer Hospital · 南昌
- The First Affiliated Hospital of Nanchang University · 南昌
- Jilin Cancer Hospital · 长春
- Liaoning Cancer Hospital · 沈阳
- The First Hospital of China Medical University · 沈阳
- Shandong Cancer Hospital · 济南
- Affiliated Hospital Of Jining Medical University · 济宁
- Linyi People's Hospital · 临沂
- Huashan Hospital, Fudan University · 上海
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine · 上海
- ZhongShan Hospital Fudan University · 上海
- Shanxi Provincial Cancer Hospitial · 太原
- The First Affiliated Hospital of Xi'an Jiaotong University · 西安
- Sichuan Cancer Hospital · 成都
- West China Hospital of Sichuan University · 成都
- Tianjin Cancer Hospital Airport Hospital · 天津
- Tianjin Cancer Hospital · 天津
- Yunnan Cancer Hospital · 昆明
- The Second Affiliated Hospital Zhejiang University School of Medicine · 杭州
- Zhejiang Cancer Hospital · 杭州
- Zhejiang Provincial People's Hospital · 杭州
- The First Affiliated Hospital of Wenzhou Medical University · 温州
公开的入选条件
- 1. Fully understand and voluntarily sign an informed consent form, willing and able to follow the study process;
- 2. Age range is 18-75 years old (inclusive);
- 3. Pancreatic cancer confirmed by histology or cytology;
- 4. Stage IV metastasis Pancreatic cancer patients;
- 5. Have not received previous systematic first line anti-tumor treatment in the stage of metastatic pancreatic cancer;
- 6. According to RECIST 1.1, there is at least one measurable lesion;
- 7. Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1;
- 8. Expected survival time ≥ 12 weeks;
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT06361888；登记信息更新于 2026-09-17。